JFS Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$425K Buy
1,008
+4
+0.4% +$1.59K 0.02% 242
2026
Q2
$364K Sell
1,004
-71
-7% -$24.3K 0.02% 263
2026
Q1
$378K Sell
1,075
-84
-7% -$29.9K 0.02% 253
2025
Q4
$379K Buy
1,159
+89
+8% +$28.2K 0.02% 248
2025
Q3
$302K Buy
1,070
+33
+3% +$9.6K 0.02% 280
2025
Q2
$290K Buy
1,037
+45
+5% +$12.7K 0.02% 262
2025
Q1
$309K Buy
992
+93
+10% +$27.5K 0.02% 254
2024
Q4
$234K Sell
899
-36
-4% -$10.7K 0.02% 274
2024
Q3
$301K Sell
935
-21
-2% -$6.87K 0.02% 250
2024
Q2
$299K Sell
956
-46
-5% -$13.5K 0.02% 194
2024
Q1
$285K Buy
1,002
+5
+0.5% +$1.46K 0.02% 207
2023
Q4
$287K Buy
997
+24
+2% +$6.54K 0.02% 196
2023
Q3
$262K Buy
973
+191
+24% +$47.7K 0.02% 192
2023
Q2
$174K Sell
782
-281
-26% -$65.2K 0.02% 232
2023
Q1
$257K Sell
1,063
-59
-5% -$14.5K 0.02% 188
2022
Q4
$295K Sell
1,122
-88
-7% -$23.6K 0.03% 183
2022
Q3
$273K Sell
1,210
-19
-2% -$4.61K 0.03% 186
2022
Q2
$299K Buy
1,229
+92
+8% +$22.5K 0.03% 175
2022
Q1
$275K Buy
1,137
+163
+17% +$37.5K 0.03% 199
2021
Q4
$219K Buy
974
+60
+7% +$12.7K 0.02% 214
2021
Q3
$194K Hold
914
– – 0.02% 219
2021
Q2
$223K Hold
914
– – 0.03% 161
2021
Q1
$227K Sell
914
-361
-28% -$86.1K 0.05% 139
2020
Q4
$293K Buy
1,275
+498
+64% +$115K 0.06% 124
2020
Q3
$197K Sell
777
-100
-11% -$24.8K 0.05% 139
2020
Q2
$207K Buy
877
+46
+6% +$10.5K 0.05% 134
2020
Q1
$168K Hold
831
– – 0.05% 136
2019
Q4
$200K Hold
831
– – 0.05% 139
2019
Q3
$161K Buy
831
+4
+0.5% +$768 0.04% 155
2019
Q2
$152K Hold
827
– – 0.04% 156
2019
Q1
$157K Sell
827
-106
-11% -$20.2K 0.04% 150
2018
Q4
$182K Sell
933
-732
-44% -$143K 0.05% 137
2018
Q3
$345K Buy
1,665
+81
+5% +$16K 0.09% 109
2018
Q2
$292K Buy
1,584
+4
+0.3% +$708 0.08% 112
2018
Q1
$269K Sell
1,580
-38
-2% -$6.98K 0.07% 121
2017
Q4
$281K Hold
1,618
– – 0.07% 117
2017
Q3
$302K Sell
1,618
-74
-4% -$13.1K 0.08% 107
2017
Q2
$291K Buy
1,692
+166
+11% +$27K 0.08% 98
2017
Q1
$223K Hold
1,526
– – 0.06% 114
2016
Q4
$223K Buy
1,526
+1,026
+205% +$154K 0.06% 114
2016
Q3
$83K Hold
500
– – 0.02% 195
2016
Q2
$76K Sell
500
-17
-3% -$2.64K 0.02% 218
2016
Q1
$78K Buy
517
+17
+3% +$2.53K 0.02% 200
2015
Q4
$81K Buy
500
+50
+11% +$7.86K 0.02% 198
2015
Q3
$62K Sell
450
-89
-17% -$14K 0.03% 190
2015
Q2
$83K Hold
539
– – 0.04% 139
2015
Q1
$86K Sell
539
-40
-7% -$6.3K 0.04% 137
2014
Q4
$92K Buy
579
+30
+5% +$4.68K 0.01% 131
2014
Q3
$77K Sell
549
-5
-0.9% -$653 0.01% 142
2014
Q2
$66K Sell
554
-1,700
-75% -$197K 0.01% 160
2014
Q1
$278K Buy
2,254
+3
+0.1% +$364 0.15% 90
2013
Q4
$257K Sell
2,251
-87
-4% -$9.9K 0.11% 108
2013
Q3
$262K Buy
2,338
+72
+3% +$7.81K 0.12% 98
2013
Q2
$224K Buy
+2,266
New +$235K 0.11% 102

Other funds holding AMGN

JFS Wealth Advisors's AMGN Position: Q3 2026 in Review

JFS Wealth Advisors increased its Amgen (AMGN) stake by 0.4% in Q3 2026, buying an estimated $1.59K and bringing the position to 1,008 shares worth $425K. The position accounts for 0.02% of the portfolio, ranked #242.

JFS Wealth Advisors first reported a position in AMGN in Q2 2013 and has held it in 54 quarters since. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • JFS Wealth Advisors held 1,008 shares of Amgen worth $425K as of Q3 2026.
  • JFS Wealth Advisors bought 4 Amgen shares in Q3 2026, an estimated $1.59K.
  • Amgen made up 0.02% of JFS Wealth Advisors's portfolio in Q3 2026, its #242 holding.
  • JFS Wealth Advisors first reported a position in Amgen in Q2 2013 and has held it in 54 quarters since.
  • 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on JFS Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.